Jerrold B. Grossman - 19 Feb 2025 Form 4 Insider Report for ADMA BIOLOGICS, INC. (ADMA)

Role
Director
Signature
/s/ Dr. Jerrold B. Grossman, by Adam S. Grossman as Attorney-in-fact
Issuer symbol
ADMA
Transactions as of
19 Feb 2025
Net transactions value
$0
Form type
4
Filing time
21 Feb 2025, 21:05:28 UTC
Previous filing
30 Aug 2024
Next filing
10 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADMA Common Stock Award $0 +10,889 +2.3% $0.000000 478,194 19 Feb 2025 Direct F1, F2
holding ADMA Common Stock 22,857 19 Feb 2025 See Footnote F3
holding ADMA Common Stock 31,381 19 Feb 2025 See Footnote F4
holding ADMA Common Stock 38,294 19 Feb 2025 See Footnote F5
holding ADMA Common Stock 175 19 Feb 2025 See Footnote F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADMA Stock Option (Right to Buy) Award $0 +16,279 $0.000000 16,279 19 Feb 2025 Common Stock 16,279 $16.07 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the Reporting Person's continued service as of the applicable vesting date.
F2 Includes, as of the transaction date, (i) 10,889 RSUs granted on February 19, 2025 and reported on this Form 4, subject to vesting as set forth in footnote (1); (ii) 12,020 restricted stock units granted on February 26, 2024, which will vest in full on February 26, 2025, subject to the Reporting Person's continued service as of the applicable vesting date; and (iii) 455,285 shares of common stock owned by the Reporting Person.
F3 These shares are owned by Brookwood LLC ("Brookwood"). The reporting person is the managing member of Brookwood.
F4 These shares are owned by the Jerrold Grossman 2019 Irrevocable Trust, of which Dr. Grossman serves as investment trustee.
F5 These shares are owned by Genesis Foundation Inc. ("Genesis"). The reporting person is the President of Genesis.
F6 These shares are owned by the Reporting Person's wife.
F7 The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.